These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24565004)

  • 1. Clinical pharmacology of eating and not eating.
    Melotto S
    Curr Opin Pharmacol; 2014 Feb; 14():1-5. PubMed ID: 24565004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy.
    Cardona Cano S; Merkestein M; Skibicka KP; Dickson SL; Adan RA
    CNS Drugs; 2012 Apr; 26(4):281-96. PubMed ID: 22452525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of new drug targets and biomarkers related to obesity and eating disorders: an approach based on reward deficit and addiction.
    Alguacil LF; Salas E; González-Martín C
    Curr Pharm Des; 2011; 17(5):462-70. PubMed ID: 21375484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrinology and brain imaging of reward in eating disorders: A possible key to the treatment of anorexia nervosa and bulimia nervosa.
    Monteleone AM; Castellini G; Volpe U; Ricca V; Lelli L; Monteleone P; Maj M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt B):132-142. PubMed ID: 28259721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy for eating disorders and obesity.
    Powers PS; Bruty H
    Child Adolesc Psychiatr Clin N Am; 2009 Jan; 18(1):175-87. PubMed ID: 19014865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacological advances in eating disorders.
    Himmerich H; Treasure J
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):95-108. PubMed ID: 28933969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin in human eating disorders.
    Jimerson DC; Lesem MD; Hegg AP; Brewerton TD
    Ann N Y Acad Sci; 1990; 600():532-44. PubMed ID: 2252333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dyslipophobias: a view of the psychopathologies involved and the hazards of construing anorexia nervosa and bulimia nervosa as 'eating disorders'.
    Crisp AH
    Proc Nutr Soc; 1995 Nov; 54(3):701-9. PubMed ID: 8643707
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacotherapy of the eating disorders: a commentary.
    Advokat C; Kutlesic V
    Neurosci Biobehav Rev; 1995; 19(1):59-66. PubMed ID: 7770198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid involvement in feeding behaviour and the pathogenesis of certain eating disorders.
    Johnson RD
    Med Hypotheses; 1995 Nov; 45(5):491-7. PubMed ID: 8748094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of eating disorders: a critical review.
    Bond WS; Crabbe S; Sanders MC
    Drug Intell Clin Pharm; 1986 Sep; 20(9):659-65. PubMed ID: 3530680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopharmacology of eating disorders.
    Mitchell JE
    Ann N Y Acad Sci; 1989; 575():41-8; discussion 49. PubMed ID: 2517383
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychopharmacological treatment of anorexia nervosa and bulimia. Review and synthesis.
    Johnson C; Stuckey M; Mitchell J
    J Nerv Ment Dis; 1983 Sep; 171(9):524-34. PubMed ID: 6310046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medial prefrontal cortex activity associated with symptom provocation in eating disorders.
    Uher R; Murphy T; Brammer MJ; Dalgleish T; Phillips ML; Ng VW; Andrew CM; Williams SC; Campbell IC; Treasure J
    Am J Psychiatry; 2004 Jul; 161(7):1238-46. PubMed ID: 15229057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taste responsiveness in eating disorders.
    Drewnowski A
    Ann N Y Acad Sci; 1989; 575():399-408; discussion 408-9. PubMed ID: 2699201
    [No Abstract]   [Full Text] [Related]  

  • 16. Ghrelin in eating disorders.
    Yi CX; Heppner K; Tschöp MH
    Mol Cell Endocrinol; 2011 Jun; 340(1):29-34. PubMed ID: 21453750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Essential Fatty Acids in Anorexia Nervosa and Obesity.
    Yehuda S; Rabinovitz S
    Crit Rev Food Sci Nutr; 2016 Sep; 56(12):2021-35. PubMed ID: 26068122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eating disorders: clinical features and pathophysiology.
    Klein DA; Walsh BT
    Physiol Behav; 2004 Apr; 81(2):359-74. PubMed ID: 15159176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eating disorders: a review of the literature with emphasis on medical complications and clinical nutrition.
    Patrick L
    Altern Med Rev; 2002 Jun; 7(3):184-202. PubMed ID: 12126461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ghrelin in the regulation of food intake in patients with obesity and anorexia nervosa.
    Dostálová I; Haluzík M
    Physiol Res; 2009; 58(2):159-170. PubMed ID: 18380540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.